Completed
Depot Disulfiram: A New Treatment for AIDS and AIDS Related Complex
What is being tested
Disulfiram
Drug
Who is being recruted
Blood-Borne Infections+14
+ Urogenital Diseases
+ Genital Diseases
Over 18 Years
+6 Eligibility Criteria
How is the trial designed
Treatment Study
Interventional
Summary
Principal SponsorSt. Vincent's Medical Center
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
This study focuses on evaluating a new treatment approach for AIDS and AIDS-related complex (ARC). The treatment in question is called depot disulfiram. The main aim is to understand if this treatment is safe and effective for individuals living with AIDS and ARC, potentially offering a new option to manage these conditions. The importance of this study lies in its potential to improve the care and treatment options available for those affected by AIDS and ARC.
Principal SponsorSt. Vincent's Medical Center
Last updated: June 24, 2005
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Blood-Borne InfectionsUrogenital DiseasesGenital DiseasesCommunicable DiseasesImmunologic Deficiency SyndromesImmune System DiseasesInfectionsRetroviridae InfectionsRNA Virus InfectionsSexually Transmitted DiseasesSlow Virus DiseasesVirus DiseasesSexually Transmitted Diseases, ViralLentivirus InfectionsAcquired Immunodeficiency SyndromeAIDS-Related ComplexHIV Infections
Criteria
5 inclusion criteria required to participate
Patient must be able to understand the study.
Patient must be strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms.
Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status.
Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria.
Show More Criteria
1 exclusion criteria prevent from participating
History of alcohol abuse.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
CompletedOne Study Center